Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BCEL

Atreca (BCEL)

Atreca Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCEL
DateTimeSourceHeadlineSymbolCompany
03/11/20243:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCELAtreca Inc
03/11/20243:10PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
02/06/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
01/05/20243:57PMEdgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:BCELAtreca Inc
12/26/20237:39AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BCELAtreca Inc
12/26/20237:38AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
12/26/20237:30AMGlobeNewswire Inc.Atreca Announces Asset Purchase Agreement for Sale of Antibody-Related Assets and Materials to ImmunomeNASDAQ:BCELAtreca Inc
11/14/20233:30PMGlobeNewswire Inc.Atreca Reports Third Quarter 2023 Financial Results and Announces Further Reorganization to Support Exploration of Strategic AlternativesNASDAQ:BCELAtreca Inc
09/27/20236:20PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
09/21/20237:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
09/21/20237:00AMGlobeNewswire Inc.Atreca Announces Agreement to Terminate Lease and Departure of Chief Financial Officer Herb CrossNASDAQ:BCELAtreca Inc
09/14/20233:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
08/17/202311:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BCELAtreca Inc
08/16/20234:20PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BCELAtreca Inc
08/10/20233:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCELAtreca Inc
08/10/20233:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BCELAtreca Inc
08/10/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCELAtreca Inc
08/10/20233:05PMGlobeNewswire Inc.Atreca Reports Second Quarter 2023 Financial Results and Announces Corporate RestructuringNASDAQ:BCELAtreca Inc
08/04/20235:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
08/04/20235:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCELAtreca Inc
07/19/20238:18AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BCELAtreca Inc
06/15/20235:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
06/15/20235:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
06/15/20235:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
06/15/20235:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
06/15/20235:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
06/15/20235:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
06/15/20235:03PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
06/15/20233:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
06/05/20237:00AMGlobeNewswire Inc.Atreca Presents Data from Ongoing Phase 1b Study of ATRC-101 in Patients with Select Advanced Solid Tumors during Oral Abstract Session at the ASCO 2023 Annual MeetingNASDAQ:BCELAtreca Inc
 Showing the most relevant articles for your search:NASDAQ:BCEL